natgillin/translations-raw huggingface dataset:
The randomised, double-blind, placebo-controlled, parallel, 3-arm study of tadalafil was conducted in 331 boys aged 7-14 years with DMD receiving concurrent corticosteroid therapy.
Randomizirano, dvojno slepo, s placebom nadzorovano paralelno študijo tadalafila s tremi skupinami preiskovancev so opravili s 331 fanti, starimi od 7 do
CIALIS 5 mg is available in blister packs containing 14, 28 or 84 tablets.
Zdravilo CIALIS 5 mg je na voljo v pretisnih omotih s 14, 28 ali 84 tabletami.
B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to medical prescription
B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Predpisovanje in izdaja zdravila je le na recept.
CIALIS has negligible influence on the ability to drive or use machines.
4.7 Vpliv na sposobnost vožnje in upravljanja strojev Zdravilo CIALIS ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
There is limited clinical data on the safety of CIALIS in patients with severe hepatic impairment (Child-Pugh Class C); if prescribed, a careful individual benefit/risk evaluation should be undertaken by the prescribing physician.
Pri bolnikih s hudo okvaro jeter (razred C po Child-Pughu) so na voljo le omejeni klinični podatki o varnosti zdravila CIALIS; v kolikor ga predpišemo, naj zdravnik, ki zdravilo predpiše, skrbno ovrednoti razmerje med koristmi in tveganjem pri posamezniku.
PHARMACEUTICAL FORM AND CONTENTS 4 film-coated tablets
FARMACEVTSKA OBLIKA IN VSEBINA 4 filmsko obložene tablete
CIALIS 20 mg film-coated tablets Aluminium/PVC blisters in cartons of 2, 4, 8, 10 and 12 film-coated tablets.
CIALIS 20 mg filmsko obložene tablete Pretisni omoti aluminij/PVC v škatlah s po 2, 4, 8, 10 in 12 filmsko obloženimi tabletami.
Ritonavir, a protease inhibitor (200 mg twice daily), which is an inhibitor of CYP3A4, CYP2C9, CYP2C19, and CYP2D6, increased tadalafil (20 mg) exposure (AUC) 2-fold with no change in Cmax.
Ritonavir, zaviralec proteaze (200 mg dvakrat na dan), ki je zaviralec CYP3A4, CYP2C9, CYP2C19 in CYP2D6, je povečal izpostavljenost (AUC) tadalafilu
Aluminium/PVC blisters in cartons of 28 film-coated tablets.
Pretisni omoti aluminij/PVC v škatlah s po 28 filmsko obloženimi tabletami.
PHARMACEUTICAL FORM AND CONTENTS 28 film-coated tablets
FARMACEVTSKA OBLIKA IN VSEBINA 28 filmsko obloženih tablet
CIALIS 2.5 mg is available in blister packs containing 28 tablets.
Zdravilo CIALIS 2,5 mg je na voljo v pretisnih omotih z 28 tabletami.
In a study to assess the effects of tadalafil on vision, no impairment of colour discrimination (blue/green) was detected using the Farnsworth-Munsell 100-hue test.
V študiji ugotavljanja učinkov tadalafila na vid z uporabo Farnsworth-Munsellovega testa s
There was no evidence of teratogenicity, embryotoxicity or foetotoxicity in rats or mice that received up to 1000 mg/kg/day tadalafil.
Pri podganah ali miših, ki so prejemale do 1000 mg/kg/dan tadalafila, ni bilo dokazov teratogenosti, embriotoksičnosti ali fetotoksičnosti.
In patients who are taking alpha1 blockers, concomitant administration of CIALIS may lead to symptomatic hypotension in some patients (see section 4.5).
Pri bolnikih, ki jemljejo antagoniste adrenergičnih receptorjev alfa1, lahko sočasno dajanje zdravila CIALIS pri nekaterih bolnikih povzroči simptomatsko hipotenzijo (glejte poglavje 4.5).
CIALIS 5 mg is used to treat adult men with: - erectile dysfunction.
Zdravilo CIALIS 5 mg je namenjeno zdravljenju odraslih moških z:
Abdominal pain, Vomiting, Nausea, Gastro-oesophageal reflux
bruhanje, navzea, gastroezofagealni refluks
CIALIS 10 mg is available in blister packs containing 4 tablets.
Zdravilo CIALIS 10 mg je na voljo v pretisnih omotih s 4 tabletami.
Major classes of antihypertensive medicinal products were studied, including calcium channel blockers (amlodipine), angiotensin converting enzyme (ACE) inhibitors (enalapril), beta-adrenergic receptor blockers (metoprolol), thiazide diuretics (bendrofluazide), and angiotensin II receptor blockers (various types and doses, alone or in combination with thiazides, calcium channel blockers, beta-blockers, and/or alpha-blockers).
Preučevali so poglavitne razrede antihipertenzivnih zdravil, vključno z antagonisti kalcijevih kanalčkov (amlodipin), zaviralci angiotenzin konvertaze (enalapril), antagonisti adrenergičnih receptorjev beta (metoprolol), tiazidnimi diuretiki (bendroflumetiazid) in antagonisti receptorjev angiotenzina II (različni tipi in odmerki, posamezno ali v kombinaciji s tiazidi, zaviralci kalcijevih kanalčkov, antagonisti adrenergičnih receptorjev beta in/ali antagonisti adrenergičnih receptorjev alfa).
Urticaria, Stevens-Johnson syndrome2, Exfoliative dermatitis2, Hyperhydrosis (sweating)
Bolezni kože in podkožja izpuščaj koprivnica, StevensJohnsonov sindrom2, eksofoliativni dermatitis2, hiperhidroza (znojenje)
Tadalafil has no effect in the absence of sexual stimulation.
Tadalafil brez spolne stimulacije nima učinka.
5.2 Pharmacokinetic properties
5.2 Farmakokinetične lastnosti Absorpcija
Tadalafil at doses of 2.5, 5, and 10 mg taken once a day was initially evaluated in 3 clinical studies involving 853 patients of various ages (range 21-82 years) and ethnicities, with erectile dysfunction of various severities (mild, moderate, severe) and etiologies.
Tadalafil v odmerkih od 2,5 mg, 5 mg in 10 mg enkrat na dan so prvotno vrednotili v 3 kliničnih študijah, ki so zajemale 853 bolnikov različnih starosti (od 21-82 let) in narodnosti, z erektilno disfunkcijo različnih resnosti (blaga, zmerna, huda) in etiologij.
In these patients the recommended dose is 5 mg taken once a day at approximately the same time of day.
Pri teh bolnikih je priporočeni odmerek 5 mg, zaužit enkrat na dan ob približno istem času dneva.
Nervous system disorders Headache
Bolezni živčevja glavobol omotica možganska kap1
Prior to initiating treatment with tadalafil for benign prostatic hyperplasia patients should be examined to rule out the presence of carcinoma of the prostate and carefully assessed for cardiovascular conditions (see section 4.3).
Pred uvedbo zdravljenja benigne hiperplazije prostate s tadalafilom je treba bolnike pregledati in izključiti prisotnost karcinoma prostate ter natančno oceniti njihove morebitne srčno-žilne bolezni
Transporters
Prenašalci
Most patients reported erectile dysfunction of at least 1 year in duration.
Večina bolnikov je poročala o erektilni disfunkciji,
For the treatment of erectile dysfunction
Za zdravljenje erektilne disfunkcije
Tadalafil exposure (AUC) in subjects with mild and moderate hepatic impairment (Child-Pugh Class A and B) is comparable to exposure in healthy subjects when a dose of 10 mg is administered.
Pri dajanju 10 mg odmerka je izpostavljenost tadalafilu (AUC) pri osebah z blago in zmerno okvaro jeter (razreda A in B po Child-Pughu) primerljiva z izpostavljenostjo pri zdravih osebah.
Cases of sudden hearing loss have been reported after the use of tadalafil.
Po uporabi tadalafila so poročali o primerih nenadne izgube sluha.
Renal insufficiency
Insuficienca ledvic
Men with diabetes Dose adjustments are not required in diabetic patients.
Moški s sladkorno boleznijo Pri bolnikih s sladkorno boleznijo odmerkov ni potrebno prilagajati.
• Drinking alcohol may affect your ability to get an erection so avoid excessive drinking with CIALIS.
• Pitje alkohola lahko vpliva na vašo sposobnost doseganja erekcije, zato se pri jemanju zdravila
The recommended dose of CIALIS is 10 mg taken prior to anticipated sexual activity and with or without food.
Priporočeni odmerek zdravila CIALIS je 10 mg, zaužit pred pričakovano spolno aktivnostjo, s hrano ali brez nje.
When dogs were treated there was reduced sperm development in the testes.
Plodnost Ko so zdravilo dajali psom, so v modih opazili zmanjšano nastajanje sperme v modih.
In general, the recommended dose is 10 mg taken prior to anticipated sexual activity and with or without food.
Običajen priporočeni odmerek je 10 mg, zaužit pred pričakovano spolno aktivnostjo, s hrano ali brez nje.
Tachycardia, Palpitations
palpitacijami in tahikardijo.
4.4 Special warnings and precautions for use
4.4 Posebna opozorila in previdnostni ukrepi Pred zdravljenjem z zdravilom CIALIS
Steady-state plasma concentrations are attained within 5 days of once-daily dosing.
Plazemske koncentracije v stanju dinamičnega ravnovesja so dosežene v 5 dneh odmerjanja enkrat na dan.
Tablet core: lactose monohydrate, croscarmellose sodium, hydroxypropylcellulose, microcrystalline cellulose, sodium laurilsulfate, magnesium stearate.
Jedro tablete: laktoza monohidrat, natrijev karmelozat, premreženi, hidroksipropilceluloza, mikrokristalna celuloza, natrijev lavrilsulfat, magnezijev stearat.
Prolonged erections Priapism, Penile haemorrhage,
Motnje reprodukcije in dojk podaljšane erekcije priapizem, krvavitev iz penisa, hematospermija
In the two primary efficacy studies of general populations, the mean per-subject proportion of successful intercourse attempts were 57 and 67 % on CIALIS 5 mg, 50 % on CIALIS 2.5 mg as compared to 31 and 37 % with placebo.
V dveh študijah primarne učinkovitosti pri splošni populaciji je bilo v povprečju pri bolnikih, zdravljenih z zdravilom CIALIS 5 mg, uspešnih 57 % in 67 % poskusov spolnega odnosa, pri bolnikih, zdravljenih z zdravilom CIALIS v odmerku 2,5 mg, pa 50 %, v primerjavi z 31 in 37 % pri placebu.
Your doctor may adjust the dose to 2.5 mg based on your response to CIALIS.
Glede na vaš odziv na zdravilo CIALIS vam bo vaš zdravnik morda prilagodil odmerek na 2,5 mg. Tega boste prejeli kot 2,5 mg tableto.
For once-a-day evaluation of tadalafil at doses of 2.5, 5, and 10 mg 3 clinical studies were initially conducted involving 853 patients of various ages (range 21-82 years) and ethnicities, with erectile dysfunction of various severities (mild, moderate, severe) and etiologies.
Za oceno, izvedeno enkrat na dan, za tadalafil v odmerkih 2,5 mg, 5 mg in 10 mg so bile prvotno opravljene 3 klinične študije, ki so zajemale 853 bolnikov različnih starosti (od 21-82 let) in narodnosti, z erektilno disfunkcijo različnih resnosti (blaga, zmerna, huda) in etiologij.
A CYP3A4 inducer, rifampicin, reduced tadalafil AUC by 88 %, relative to the AUC values for tadalafil alone (10 mg).
Induktorji citokroma P450 Induktor CYP3A4, rifampicin, je AUC tadalafila zmanjšal za 88 % v primerjavi z vrednostmi AUC za sam tadalafil (10 mg).
In clinical studies, tadalafil was shown to augment the hypotensive effects of nitrates.
V kliničnih študijah je bilo dokazano, da tadalafil okrepi hipotenzivne učinke nitratov.
The recommended dose is one 5 mg tablet taken once a day at approximately the same time of the day.
Priporočeni odmerek je ena 5 mg tableta enkrat na dan ob približno istem času dneva.
Thus, in a patient prescribed any dose of CIALIS (2.5 mg-20 mg), where nitrate administration is deemed medically necessary in a life-threatening situation, at least 48 hours should have elapsed after the last dose of CIALIS before nitrate administration is considered.
Zato naj pri bolniku, ki ima predpisan katerikoli odmerek zdravila CIALIS (2,5 mg-20 mg) in kjer je dajanje nitrata zdravstveno nujno v življenje ogrožajoči situaciji, preden razmislimo o dajanju nitrata preteče vsaj 48 ur po zadnjem odmerku zdravila CIALIS.
CIALIS 20 mg film-coated tablets Each tablet contains 20 mg tadalafil.
CIALIS 20 mg filmsko obložene tablete Ena tableta vsebuje 20 mg tadalafila.
Tadalafil 10 and 20 mg is intended for use prior to anticipated sexual activity and it is not recommended for continuous daily use.
Tadalafil v odmerku 10 in 20 mg je namenjen za uporabo pred pričakovano spolno aktivnostjo in ga ne priporočamo za dolgotrajno vsakodnevno uporabo.
The improvement in the total international prostate symptom score with CIALIS 5mg in the four studies were -4.8, -5.6, -6.1 and -6.3 compared to -2.2,3.6, -3.8 and -4.2 with placebo.
-4,8, -5,6, -6,1 in -6,3 v primerjavi z -2,2, -3,6, -3,8 in -4,2 s placebom.
Myocardial infarction, Unstable angina pectoris2, Ventricular arrhythmia2
tahikardija, palpitacije miokardni infarkt, nestabilna angina pektoris2, prekatna aritmija2
As a precautionary measure, it is preferable to avoid the use of CIALIS during pregnancy.
Med nosečnostjo odsvetujemo uporabo zdravila CIALIS.
Men with renal impairment
Moški z okvaro ledvic
Blurred vision, Sensations described as eye pain
Očesne bolezni zamegljen vid, občutki opisani kot bolečina v očeh izpad v vidnem polju,
When taken once a day CIALIS allows you to obtain an erection, when sexually stimulated, at any time point during the 24 hours of the day.
Jemanje zdravila CIALIS enkrat na dan vam bo ob spolni stimulaciji omogočilo doseganje erekcije, kadarkoli tekom 24 ur dneva.
A selective inhibitor of CYP3A4, ketoconazole (200 mg daily), increased tadalafil (10 mg) exposure (AUC) 2-fold and Cmax by 15 %, relative to the AUC and Cmax values for tadalafil alone.
Selektivni zaviralec CYP3A4, ketokonazol (200 mg na dan) je povečal izpostavljenost (AUC) tadalafilu (10-mg) za 2-krat in Cmax za 15 % glede na vrednosti AUC in Cmax za sam tadalafil.
There are no available data about the administration of once-a-day dosing of tadalafil to patients with hepatic impairment.
Podatkov o dajanju odmerkov tadalafila enkrat na dan bolnikom z okvaro jeter ni.
Treatment of erectile dysfunction in adult males.
Zdravljenje erektilne disfunkcije pri odraslih moških.
MARKETING AUTHORISATION HOLDER Eli Lilly Nederland B.V.
IMETNIK DOVOLJENJA ZA PROMET Eli Lilly Nederland B.V.
Tadalafil has no effect in the treatment of erectile dysfunction in the absence of sexual stimulation.
Tadalafil pri zdravljenju erektilne disfunkcije brez spolne stimulacije nima učinka.
In the primary efficacy studies, 75 % of intercourse attempts were successful in CIALIS treated patients as compared to 32 % with placebo.
V primarnih študijah učinkovitosti je bilo pri bolnikih, zdravljenih z zdravilom CIALIS, uspešnih 75 % poskusov spolnega odnosa v primerjavi z 32 % pri placebu.
Serious cardiovascular events, including myocardial infarction, sudden cardiac death, unstable angina pectoris, ventricular arrhythmia, stroke, transient ischemic attacks, chest pain, palpitations and tachycardia, have been reported either post marketing and/or in clinical trials.
Srčnožilni dogodki V obdobju trženja zdravila in/ali kliničnih preskušanj so bili opisani resni srčnožilni dogodki, vključno z miokardnim infarktom, nenadno srčno smrtjo, nestabilno angino pektoris, ventrikularno aritmijo, možgansko kapjo, tranzitorno ishemično atako, bolečinami v prsnem košu, palpitacijami in tahikardijo.
NN:
Ti vključujejo:
Tadalafil (20 mg) did not augment the mean blood pressure decrease produced by alcohol (0.7 g/kg or approximately 180 ml of 40 % alcohol [vodka] in an 80-kg male) but in some subjects, postural dizziness and orthostatic hypotension were observed.
Tadalafil (20 mg) ni povečal povprečnega znižanja krvnega tlaka, ki ga je povzročil alkohol (0,7 g/kg ali približno 180 ml
CIALIS 10 mg and 20 mg is intended for use prior to anticipated sexual activity and is not recommended for continuous daily use.
Zdravilo CIALIS 10 mg in 20 mg je namenjeno za uporabo pred pričakovano spolno aktivnostjo in ga ne priporočamo za dolgotrajno vsakodnevno uporabo.
Film-coat: lactose monohydrate, hypromellose, triacetin, titanium dioxide (E171), iron oxide yellow (E172), iron oxide red (E172), talc.
Filmska obloga: laktoza monohidrat, hipromeloza, triacetin, titanov dioksid (E171), rumeni železov oksid (E172), rdeči železov oksid (E172), smukec.
Anti-hypertensives (including calcium channel blockers) The co-administration of doxazosin (4 and 8 mg daily) and tadalafil (5 mg daily dose and 20 mg as a single dose) increases the blood pressure-lowering effect of this alpha-blocker in a significant manner.
Sočasno jemanje doksazosina (4 mg in 8 mg na dan) in tadalafila (dnevni odmerek 5 mg in enkratni odmerek 20 mg) signifikantno okrepi hipotenzivni učinek antagonista adrenergičnih receptorjev alfa.
A slightly higher incidence of ECG abnormalities, primarily sinus bradycardia, has been reported in patients treated with tadalafil once a day as compared with placebo.
Pri bolnikih, ki so bili zdravljeni s tadalafilom z odmerjanjem enkrat na dan, so v primerjavi s placebom poročali o nekoliko povečani incidenci nepravilnosti EKG-ja, zlasti sinusni bradikardiji.
The mean persubject proportion of successful sexual intercourse attempts was 68 % for CIALIS patients compared to 52 % for patients on placebo.
Pri bolnikih, ki so jemali zdravilo CIALIS, je bilo v povprečju uspešnih 68 % poskusov spolnega odnosa, v primerjavi z 52 % pri bolnikih, ki so jemali placebo.
The most commonly reported adverse reactions in patients taking CIALIS for the treatment of erectile dysfunction or benign prostatic hyperplasia were headache, dyspepsia, back pain and myalgia, in which the incidences increase with increasing dose of CIALIS.
Neželeni učinki, o katerih so pri bolnikih, ki so jemali zdravilo CIALIS za zdravljenje erektilne disfunkcije ali benigne hiperplazije prostate, najpogosteje poročali, so bili glavobol, dispepsija,
Adult men
Odmerjanje Odrasli moški
When taken once a day for erectile dysfunction, CIALIS allows you to obtain an erection, when sexually stimulated, at any time point during the 24 hours of the day.
Jemanje zdravila CIALIS enkrat na dan za zdravljenje erektilne disfunkcije vam bo ob spolni stimulaciji omogočilo doseganje erekcije, kadarkoli tekom 24 ur dneva.
Patients who are unable to tolerate tadalafil 5 mg for the treatment of benign prostatic hyperplasia should consider an alternative therapy as the efficacy of tadalafil 2.5mg for the treatment of benign prostatic hyperplasia has not been demonstrated.
naj razmislijo o alternativnem zdravljenju, saj učinkovitost tadalafila v odmerku 2,5 mg za zdravljenje benigne hiperplazije prostate ni bila dokazana.
Film-coat: lactose monohydrate, hypromellose, triacetin, titanium dioxide (E171), iron oxide yellow (E172), talc.
Filmska obloga: laktoza monohidrat, hipromeloza, triacetin, titanov dioksid (E171), rumeni železov oksid (E172), smukec.
INFORMATION IN BRAILLE cialis 20 mg
PODATKI V BRAILLOVI PISAVI cialis 20 mg
A medical history and physical examination should be undertaken to diagnose erectile dysfunction or benign prostatic hyperplasia and determine potential underlying causes, before pharmacological treatment is considered.
Preden začnemo razmišljati o farmakološkem zdravljenju, je za diagnozo erektilne disfunkcije ali benigne hiperplazije prostate in določitev možnih temeljnih vzrokov potrebno vzeti anamnezo in pregledati bolnika.
Each tablet contains 20 mg of tadalafil.
Ena tableta vsebuje 20 mg tadalafila.
In the study in patients with erectile dysfunction secondary to diabetes, the mean per-subject proportion of successful attempts were 41 and 46 % on CIALIS 5 mg and 2.5 mg, respectively, as compared to 28 % with placebo.
V študiji pri sladkornih bolnikih z erektilno disfunkcijo, ki se je pojavila sekundarno zaradi sladkorne bolezni je bilo v povprečju pri bolnikih, zdravljenih z zdravilom CIALIS v odmerku 5 mg oziroma 2,5 mg, uspešnih 41 in 46 % poskusov spolnega odnosa, v primerjavi z 28 % pri placebu.
Each tablet contains 2.5 mg of tadalafil.
Ena tableta vsebuje 2,5 mg tadalafila.
Aluminium/PVC blisters in cartons of 14, 28 or 84 film-coated tablets.
6.5 Vrsta ovojnine in vsebina Pretisni omoti aluminij/PVC v škatlah s po 14, 28 ali 84 filmsko obloženimi tabletami.
Facial oedema2,
tranzitorna ishemična ataka1,
Hepatic impairment
Srčno-žilni dogodki
INFORMATION IN BRAILLE cialis 2.5 mg
PODATKI V BRAILLOVI PISAVI cialis 2,5 mg
• Always take CIALIS exactly as your doctor has told you.
• Pri jemanju zdravila CIALIS natančno upoštevajte zdravnikova navodila.
The effect of alcohol on cognitive function was not augmented by tadalafil (10 mg).
ni okrepil učinka alkohola na kognitivne funkcije.
Once-a-day dosing of CIALIS both for the treatment of erectile dysfunction and benign prostatic hyperplasia has not been evaluated in patients with hepatic impairment; therefore, if prescribed, a careful individual benefit/risk evaluation should be undertaken by the prescribing physician (see sections 4.4 and 5.2).
Pri bolnikih z okvaro jeter niso ocenjevali odmerjanja zdravila CIALIS enkrat na dan za zdravljenje erektilne disfunkcije in benigne hiperplazije prostate; torej, v kolikor ga predpišemo, naj zdravnik, ki zdravilo predpiše, skrbno ovrednoti razmerje med koristmi in tveganjem pri posamezniku (glejte poglavji 4.4 in 5.2).
Each coated tablet contains 87 mg of lactose (as monohydrate).
Ena obložena tableta vsebuje 87 mg laktoze (v obliki monohidrata).
Light orange-yellow and almond shaped tablets, marked "C 2 ½" on one side.
Tablete svetlo oranžne barve in mandljeve oblike, z oznako "C 2 ½" na eni strani.
There is limited clinical data on the safety of CIALIS in patients with severe hepatic insufficiency (ChildPugh Class C).
O varnosti zdravila CIALIS pri bolnikih s hudo insuficienco jeter (razred C po Child-Pughu) obstajajo le omejeni klinični podatki.
Musculoskeletal, connective tissue and bone disorders Back pain,
Bolezni mišično-skeletnega sistema in vezivnega tkiva bolečina v hrbtu, mialgija, bolečina v okončinah
Once-a-day dosing has not been evaluated in patients with hepatic impairment; therefore, if prescribed, a careful individual benefit/risk evaluation should be undertaken by the prescribing physician (see sections 4.4 and 5.2).
Pri bolnikih z okvaro jeter niso ocenjevali odmerjanja enkrat na dan; torej, v kolikor ga predpišemo, naj zdravnik, ki zdravilo predpiše, skrbno ovrednoti razmerje med koristmi in tveganjem pri posamezniku (glejte poglavji 4.4 in 5.2).
CIALIS contains lactose: If you have an intolerance to some sugars, contact your doctor before taking this medicine.
Če ne prenašate nekaterih sladkorjev, se posvetujte s svojim zdravnikom pred jemanjem tega zdravila.
- The other ingredients are: Tablet core: lactose monohydrate (see end of section 2), croscarmellose sodium, hydroxypropylcellulose, microcrystalline cellulose, sodium laurilsulfate, magnesium stearate.
Jedro tablete: laktoza monohidrat (glejte zaključek poglavja 2), premreženi natrijev karmelozat, hidroksipropilceluloza, mikrokristalna celuloza, natrijev lavrilsulfat, magnezijev stearat.
CIALIS 2.5 mg is a light orange-yellow film-coated tablet in the shape of an almond and has "C 2 ½" marked on one side.
Tablete CIALIS 2,5 mg so svetlo oranžno-rumene filmsko obložene tablete v obliki mandlja in imajo na eni strani oznako "C 2 ½".
Each coated tablet contains 121 mg lactose (as monohydrate).
Ena obložena tableta vsebuje 121 mg laktoze (v obliki monohidrata).
Decreased or sudden hearing loss has been noted in some patients taking tadalafil.
Pri nekaterih bolnikih, ki so jemali tadalafil, so opazili poslabšanje ali nenadno izgubo sluha.
Each coated tablet contains 233 mg lactose (as monohydrate).
Ena obložena tableta vsebuje 233 mg laktoze (v obliki monohidrata).
Alcohol concentrations (mean maximum blood concentration 0.08 %) were not affected by coadministration with tadalafil (10 mg or 20 mg).
Sočasno dajanje tadalafila (10 ali 20 mg) ni vplivalo na koncentracije alkohola (povprečna maksimalna koncentracija v krvi 0,08 %).
INFORMATION IN BRAILLE cialis 10 mg
PODATKI V BRAILLOVI PISAVI cialis 10 mg
INFORMATION IN BRAILLE cialis 5 mg
PODATKI V BRAILLOVI PISAVI cialis 5 mg
Uncommon (seen in 1 to 10 in every 1,000 patients) - dizziness, stomach ache, feeling sick, being sick (vomiting), reflux, blurred vision, eye pain, difficulty in breathing, presence of blood in urine, prolonged erection, pounding heartbeat sensation, a fast heart rate, high blood pressure, low blood pressure, nose bleeds, ringing in the ears, swelling of the hands, feet or ankles and feeling tired.
težave pri dihanju, prisotnost krvi v urinu, podaljšana erekcija, občutek razbijanja srca, hitro bitje srca, visok krvni tlak, nizek krvni tlak, krvavitve iz nosu, zvonjenje v ušesih, otekanje dlani, stopal ali gležnjev in občutek utrujenosti.
MARKETING AUTHORISATION NUMBER(S) EU/1/02/237/007-008, 010
ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/02/237/007-008, 010
How to store CIALIS
Shranjevanje zdravila CIALIS
Each tablet contains 5 mg of tadalafil.
Ena tableta vsebuje 5 mg tadalafila.
- a severe kidney problem.
- resne težave z ledvicami.